SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-17-206412
Filing Date
2017-06-19
Accepted
2017-06-19 07:00:42
Documents
14
Effectiveness Date
2017-06-19

Document Format Files

Seq Description Document Type Size
1 DEFM14A d320129ddefm14a.htm DEFM14A 3974321
2 GRAPHIC g3201291_1.jpg GRAPHIC 630
3 GRAPHIC g3201291_2.jpg GRAPHIC 622
4 GRAPHIC g3201291_3.jpg GRAPHIC 711
5 GRAPHIC g3201291_4.jpg GRAPHIC 914
6 GRAPHIC g3201291_5.jpg GRAPHIC 1346
7 GRAPHIC g3201291_6.jpg GRAPHIC 1690
8 GRAPHIC g3201291_7.jpg GRAPHIC 1773
9 GRAPHIC g3201291_8.jpg GRAPHIC 616
10 GRAPHIC g3201291_9.jpg GRAPHIC 1378
11 GRAPHIC g3201292_1.jpg GRAPHIC 4101
12 GRAPHIC g3201292_2.jpg GRAPHIC 1666
13 GRAPHIC g320129g79h75.jpg GRAPHIC 35710
14 GRAPHIC g320129g80k56.jpg GRAPHIC 33036
  Complete submission text file 0001193125-17-206412.txt   4092289
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-36395 | Film No.: 17917465
SIC: 2834 Pharmaceutical Preparations